1. Leiferman KM: A current perspective on the role of eosinophils in dermatologic diseases. J Am Acad Dermatol 24(6 Pt 2):1101-1112, 1991
2. Gleich GJ: Mechanisms of eosinophil-associated inflammation. J Allergy Clin Immunol 105(4):651-663, 2000
3. Rothenberg ME, Hogan SP: The eosinophil. Annu Rev Immunol 24:147-174, 2006
4. Simon D, Wardlaw A, Rothenberg ME: Organ-specific eosinophilic disorders of the skin, lung, and gastrointestinal tract. J Allergy Clin Immunol 126(1):3-13, 2010
5. Zuo L, Rothenberg ME: Gastrointestinal eosinophilia.
Immunol Allergy Clin North Am 27(3):443-455, 2007
[PubMed: 2034402]
6. Wechsler ME: Pulmonary eosinophilic syndromes. Immunol Allergy Clin North Am 27(3):477-492, 2007
7. Klion AD, Nutman TB: The role of eosinophils in host defense against helminth parasites. J Allergy Clin Immunol 113(1):30-37, 2004
8. Kephart GM, Andrade ZA, Gleich GJ: Localization of eosinophil major basic protein onto eggs of Schistosoma mansoni in human pathologic tissue. Am J Pathol 133(2):389-396, 1988
9. Emmerson RW, Wilson-Jones E: Eosinophilic spongiosis in pemphigus. A report of an unusual hitological change in pemphigus. Arch Dermatol 97(3):252-257, 1968
10. Crotty C, Pittelkow M, Muller SA: Eosinophilic spongiosis: A clinicopathologic review of seventy-one cases. J Am Acad Dermatol 8(3):337-343, 1983
11. Winkelmann RK, Frigas E: Eosinophilic panniculitis: A clinicopathologic study. J Cutan Pathol 13(1):1-12, 1986
12. Adame J, Cohen PR: Eosinophilic panniculitis: Diagnostic considerations and evaluation. J Am Acad Dermatol 34(2 Pt 1):229-234, 1996
13. Trocme SD et al: Extracellular deposition of eosinophil major basic protein in orbital histiocytosis X. Ophthalmology 98(3):353-356, 1991
14. Quaedvlieg PJ et al: Histopathological characteristics of metastasizing squamous cell carcinoma of the skin and lips. Histopathology 49(3):256-264, 2006
15. Butterfield JH et al: Extracellular deposition of eosinophil granule major basic protein in lymph nodes of patients with Hodgkin's disease. Blood 68(6):1250-1256, 1986
16. Weaver J, Bergfeld WF: Quantitative analysis of eosinophils in acute graft-versus-host disease compared with drug hypersensitivity reactions. Am J Dermatopathol 32(1):31-34, 2010
17. Marra DE, McKee PH, Nghiem P: Tissue eosinophils and the perils of using skin biopsy specimens to distinguish between drug hypersensitivity and cutaneous graft-versus-host disease. J Am Acad Dermatol 51(4):543-546, 2004
18. Leiferman KM, Peters MS, Gleich GJ: The eosinophil and cutaneous edema. J Am Acad Dermatol 15(3):513-517, 1986
19. Romero LS, Kantor GR: Eosinophils are not a clue to the pathogenesis of granuloma annulare. Am J Dermatopathol 20(1):29-34, 1998
20. Hardy WR, Anderson RE: The hypereosinophilic syndromes. Ann Intern Med 68:1220-1229, 1968
21. Chusid MJ et al: The hypereosinophilic syndrome: Analysis of fourteen cases with review of the literature. Medicine (Baltimore) 54(1):1-27, 1975
22. Simon HU et al: Abnormal clones of T cells producing interleukin-5 in idiopathic eosinophilia. N Engl J Med 341(15):1112-1120, 1999
23. Roufosse F, Cogan E, Goldman M: Recent advances in pathogenesis and management of hypereosinophilic syndromes. Allergy 59(7):673-689, 2004
24. Gleich GJ et al: Treatment of hypereosinophilic syndrome with
imatinib mesilate.
Lancet 359(9317):1577-1578, 2002
25. Cools J et al: A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of
imatinib in idiopathic hypereosinophilic syndrome.
N Engl J Med 348(13):1201-11214, 2003
26. Gotlib J et al: The FIP1L1-PDGFRalpha fusion tyrosine kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia: implications for diagnosis, classification, and management. Blood 103(8):2879-2791, 2004
27. Bain BJ, Fletcher SH: Chronic eosinophilic leukemias and the myeloproliferative variant of the hypereosinophilic syndrome. Immunol Allergy Clin North Am 27(3):377-388, 2007
28. Gleich GJ, Leiferman KM: The hypereosinophilic syndromes: Still more heterogeneity. Curr Opin Immunol 17(6):679-684, 2005
29. Klion AD et al: Approaches to the treatment of hypereosinophilic syndromes: A workshop summary report. J Allergy Clin Immunol 117(6):1292-1302, 2006
30. Simon HU et al: Refining the definition of hypereosinophilic syndrome. J Allergy Clin Immunol 126(1):45-49, 2010
31. Rothenberg ME: Eosinophilic gastrointestinal disorders (EGID). J Allergy Clin Immunol 113(1):11-28, quiz 29, 2004
32. Noel RJ, Putnam PE, Rothenberg ME: Eosinophilic esophagitis. N Engl J Med 351(9):940-941, 2004
33. Bochner BS, Gleich GJ: What targeting eosinophils has taught us about their role in diseases. J Allergy Clin Immunol 126(1):16-25, 2010
34. Roufosse F, Cogan E, Goldman M: Lymphocytic variant hypereosinophilic syndromes. Immunol Allergy Clin N Am 27:389-413, 2007
35. Pardanani A et al: FIP1L1-PDGFRA fusion: prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophilia. Blood 104(10):3038-3045, 2004
36. Tefferi A, Pardanani A, Li CY: Hypereosinophilic syndrome with elevated serum tryptase versus systemic mast cell disease associated with eosinophilia: 2 distinct entities? Blood 102(8):3073-3074, author reply 3074, 2003
37. Pardanani A et al: CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to
imatinib mesylate therapy.
Blood 102(9):3093-3096, 2003
38. Yamada Y et al: The FIP1L1-PDGFRA fusion gene cooperates with IL-5 to induce murine hypereosinophilic syndrome (HES)/chronic eosinophilic leukemia (CEL)-like disease. Blood 107(10):4071-4079, 2006
39. Yamada Y, Cancelas JA: FIP1L1/PDGFR alpha-associated systemic mastocytosis. Int Arch Allergy Immunol 152(Suppl. 1):101-105, 2010
40. Vardiman JW et al: The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 114(5):937-951, 2009
41. Tefferi A, Thiele J, Vardiman JW: The 2008 World Health Organization classification system for myeloproliferative neoplasms: Order out of chaos. Cancer 115(17):3842-3847, 2009
42. Gleich GJ et al: Episodic angioedema associated with eosinophilia. N Engl J Med 310(25):1621-1626, 1984
43. Butterfield JH, Leiferman KM, Gleich GJ: Nodules, eosinophilia, rheumatism, dermatitis and swelling (NERDS): A novel eosinophilic disorder. Clin Exp Allergy 23(7):571-580, 1993
44. Roufosse F, Weller PF: Practical approach to the patient with hypereosinophilia. J Allergy Clin Immunol 126(1):39-44, 2010
45. Ogbogu PU et al: Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy.
J Allergy Clin Immunol 124(6):1319-1325, e3, 2009
[PubMed: 2829669]
46. Sheikh J, Weller PF: Clinical overview of hypereosinophilic syndromes. Immunol Allergy Clin North Am 27(3):333-355, 2007
47. van den Hoogenband HM: Skin lesions as the first manifestation of the hypereosinophilic syndrome. Clin Exp Dermatol 7(3):267-271, 1982
48. Leiferman KM, Gleich GJ, Peters MS: Dermatologic manifestations of the hypereosinophilic syndromes. Immunol Allergy Clin North Am 27(3):415-441, 2007
49. Roufosse F, Simonart T, Cogan E: Skin lesions as the only manifestation of the idiopathic hypereosinophilic syndrome. Br J Dermatol 144(3):639, 2001
50. Offidani A et al: Hypereosinophilic dermatosis: skin lesions as the only manifestation of the idiopathic hypereosinophilic syndrome? Br J Dermatol 143(3):675-677, 2000
51. Barna M, Kemeny L, Dobozy A: Skin lesions as the only manifestation of the hypereosinophilic syndrome. Br J Dermatol 136(4):646-647, 1997
52. Kazmierowski JA et al: Dermatologic manifestations of the hypereosinophilic syndrome. Arch Dermatol 114(4):531-535, 1978
53. Miljkovic J, Bartenjev I: Hypereosinophilic dermatitis-like erythema annulare centrifugum in a patient with chronic lymphocytic leukaemia. J Eur Acad Dermatol Venereol 19(2):228-231, 2005
54. Calux MJ et al: [Hypereosinophilic syndrome. Cutaneous picture of “erythema annulare centrifugum”–Comparison with ultrastructural study]. [Article in Portuguese.] Med Cutan Ibero Lat Am 16(4):299-304, 1988
55. Shelley WB, Shelley ED: Erythema annulare centrifugum as the presenting sign of the hypereosinophilic syndrome: Observations on therapy. Cutis 35(1):53-55, 1985
56. Hofmann SC et al: Bullous pemphigoid associated with hypereosinophilic syndrome: Simultaneous response to
imatinib.
J Am Acad Dermatol 56(Suppl. 5):S68-S72, 2007
57. McPherson T et al: Platelet-derived growth factor receptor-alpha-associated hypereosinophilic syndrome and lymphomatoid papulosis. Br J Dermatol 155(4):824-826, 2006
58. Jang KA et al: Hypereosinophilic syndrome presenting as cutaneous necrotizing eosinophilic vasculitis and Raynaud's phenomenon complicated by digital gangrene. Br J Dermatol 143(3):641-644, 2000
59. Kim SH et al: Hypereosinophilia presenting as eosinophilic vasculitis and multiple peripheral artery occlusions without organ involvement. J Korean Med Sci 20(4):677-679, 2005
60. Ito K et al: Hypereosinophilic syndrome with various skin lesions and juvenile temporal arteritis. Clin Exp Dermatol 34(5):e192-e195, 2009
61. Hayashi M et al: Case of hypereosinophilic syndrome with cutaneous necrotizing vasculitis. J Dermatol 35(4):229-233, 2008
62. Tsuji Y et al: Wells' syndrome as a manifestation of hypereosinophilic syndrome. Br J Dermatol 147(4):811-812, 2002
63. Bogenrieder T et al: Wells' syndrome associated with idiopathic hypereosinophilic syndrome. Br J Dermatol 137(6):978-982, 1997
64. Leiferman KM, Gleich GJ: Hypereosinophilic syndrome: Case presentation and update. J Allergy Clin Immunol 113(1):50-58, 2004
65. Vandenberghe P et al: Clinical and molecular features of FIP1L1-PDFGRA (+) chronic eosinophilic leukemias. Leukemia 18(4):734-742, 2004
66. Leiferman KM et al: Recurrent incapacitating mucosal ulcerations. A prodrome of the hypereosinophilic syndrome. JAMA 247(7):1018-1020, 1982
67. Ogbogu PU, Rosing DR, Horne MK III. Cardiovascular manifestations of hypereosinophilic syndromes.
Immunol Allergy Clin North Am 27(3):457-475, 2007
[PubMed: 2048688]
68. Fuzellier JF, Chapoutot L, Torossian PF: Mitral valve repair in idiopathic hypereosinophilic syndrome. J Heart Valve Dis 13(3):529-531, 2004
69. Blauwet LA et al: Atypical presentation of eosinophilic endomyocardial disease. Mayo Clin Proc 80(8):1078-1084, 2005
70. Klion A: Hypereosinophilic syndrome: Current approach to diagnosis and treatment. Annu Rev Med 60:293-306, 2009
71. Gleich GJ, Leiferman KM: The hypereosinophilic syndromes: Current concepts and treatments. Br J Haematol 145(3):271-285, 2009
72. Tefferi A, Gotlib J, Pardanani A: Hypereosinophilic syndrome and clonal eosinophilia: Point-of-care diagnostic algorithm and treatment update.
Mayo Clin Proc 85(2):158-164, 2010
[PubMed: 2813824]
73. Plager DA et al: Eosinophil ribonucleases and their cutaneous lesion-forming activity.
J Immunol 183(6):4013-4020, 2009
[PubMed: 2852253]
74. Nutman TB: Evaluation and differential diagnosis of marked, persistent eosinophilia.
Immunol Allergy Clin North Am 27(3):529-549, 2007.
[PubMed: 2099264]
75. Lee JS et al: Prolonged urticaria with purpura: The spectrum of clinical and histopathologic features in a prospective series of 22 patients exhibiting the clinical features of urticarial vasculitis. J Am Acad Dermatol 56(6):994-1005, 2007
76. Amano H, Nagai Y, Ishikawa O: Persistent urticaria characterized by recurrent lasting urticarial erythema with histological features of prominent perivascular eosinophilic infiltration. Clin Exp Dermatol 34(5):e14-e17, 2009
77. Klion AD: Approach to the therapy of hypereosinophilic syndromes. Immunol Allergy Clin North Am 27(3):551-560, 2007
78. Simon HU, Cools J: Novel approaches to therapy of hypereosinophilic syndromes. Immunol Allergy Clin North Am 27(3):519-527, 2007
79. Pitini V et al: Serum concentration of cardiac Troponin T in patients with hypereosinophilic syndrome treated with
imatinib is predictive of adverse outcomes.
Blood 102(9):3456-3457, author reply 3457, 2003
80. Sato Y et al: Measurement of serum concentrations of cardiac troponin T in patients with hypereosinophilic syndrome: A sensitive non-invasive marker of cardiac disorder. Intern Med 39(4):350, 2000
81. Burgess MR, Sawyers CL: Treating imatinib-resistant leukemia: The next generation targeted therapies. Scientific World J 6:918-930, 2006
82. O'Hare T, Corbin AS, Druker BJ: Targeted CML therapy: Controlling drug resistance, seeking cure. Curr Opin Genet Dev 16(1):92-99, 2006
83. Simon D et al: Primary resistance to
imatinib in Fip1-like 1-platelet-derived growth factor receptor alpha-positive eosinophilic leukemia.
J Allergy Clin Immunol 121:1054-1056, 2008
84. Scowden EB, Schaffner W, Stone WJ: Overwhelming strongyloidiasis: An unappreciated opportunistic infection. Medicine (Baltimore) 57(6):527-544, 1978
85. Rotoli B et al: Rapid reversion of Loeffler's endocarditis by
imatinib in early stage clonal hypereosinophilic syndrome.
Leuk Lymphoma 45(12):2503-2507, 2004
86. Klion AD et al: Molecular remission and reversal of myelofibrosis in response to
imatinib mesylate treatment in patients with the myeloproliferative variant of hypereosinophilic syndrome.
Blood 103(2):473-478, 2004
87. Butterfield JH: Interferon treatment for hypereosinophilic syndromes and systemic mastocytosis. Acta Haematol 114(1):26-40, 2005
88. Butterfield JH: Treatment of hypereosinophilic syndromes with
prednisone,
hydroxyurea, and interferon.
Immunol Allergy Clin North Am 27(3):493-518, 2007
89. Cervetti G et al:
Imatinib therapy in Hypereosinophilic Syndrome: A case of molecular remission.
Leuk Res 29(9):1097-1098, 2005
90. Tefferi A: Modern diagnosis and treatment of primary eosinophilia. Acta Haematol 114(1):52-60, 2005
91. Taverna JA et al:
Infliximab as a therapy for idiopathic hypereosinophilic syndrome.
Arch Dermatol 143(9):1110-1112, 2007
92. Sefcick A et al:
Alemtuzumab therapy for refractory idiopathic hypereosinophilic syndrome.
Br J Haematol 124(4):558-559, 2004
93. Wagner LA et al: Treatment of FIP1L1/PDGFRA-negative hypereosinophilic syndrome with
alemtuzumab, an anti-CD52 antibody.
J Allergy Clin Immunol 123(6):1407-1408, 2009
94. Pitini V et al:
Alemtuzumab therapy for refractory idiopathic hypereosinophilic syndrome with abnormal T cells: A case report.
Br J Haematol 127(5):477, 2004
95. Halaburda K et al: Allogeneic bone marrow transplantation for hypereosinophilic syndrome: Long-term follow-up with eradication of FIP1L1-PDGFRA fusion transcript. Bone Marrow Transplant 38(4):319-320, 2006
96. Ueno NT et al: Successful non-myeloablative allogeneic transplantation for treatment of idiopathic hypereosinophilic syndrome. Br J Haematol 119(1):131-134, 2002
97. Walsh GM:
Reslizumab, a humanized anti-IL-5 mAb for the treatment of eosinophil-mediated inflammatory conditions.
Curr Opin Mol Ther 11(3):329-336, 2009
98. Klion AD et al: Safety and efficacy of the monoclonal anti-interleukin-5 antibody SCH36 in the treatment of patients with hypereosinophilic syndrome. Blood 103(8):2939-2941, 2004
99. Rothenberg ME et al: Treatment of patients with the hypereosinophilic syndrome with
mepolizumab.
N Engl J Med 358(12):1215-1228, 2008
100. Plotz SG et al: Use of an anti-interleukin-5 antibody in the hypereosinophilic syndrome with eosinophilic dermatitis. N Engl J Med 349(24):2334-2339, 2003
101. Boucher RM, Gilbert-McClain L, Chowdhury B: Hypereosinophilic syndrome and
mepolizumab.
N Engl J Med 358(26):2838-2839, author reply 2839-2840, 2008
102. Wells GC: Recurrent granulomatous dermatitis with eosinophilia. Trans St Johns Hosp Dermatol Soc 57:46-56, 1971
103. Wells GC, Smith NP: Eosinophilic cellulitis. Br J Dermatol 100(1):101-109, 1979
104. Spigel GT, Winkelmann RK: Wells' syndrome. Recurrent granulomatous dermatitis with eosinophilia. Arch Dermatol 115(5):611-613, 1979
105. Leiferman KM, Peters MS: Reflections on eosinophils and flame figures: Where there's smoke there's not necessarily Wells syndrome. Arch Dermatol 142(9):1215-1218, 2006
106. Van den Hoogenband HM: Eosinophilic cellulitis as a result of onchocerciasis. Clin Exp Dermatol8:405-408, 1983
107. Fisher GB, Greer KE, Cooper PH: Eosinophilic cellulitis (Wells' syndrome). Int J Dermatol 24(2):101-107, 1985
108. Gilliam AE et al: Bullous “cellulitis” with eosinophilia: case report and review of Wells' syndrome in childhood. Pediatrics 116(1):e149-e155, 2005
109. Ling
TC et al: Two cases of bullous eosinophilic cellulitis.
Br J Dermatol 146(1):160-161, 2002
110. Schuttelaar ML, Jonkman MF: Bullous eosinophilic cellulitis (Wells' syndrome) associated with Churg-Strauss syndrome. J Eur Acad Dermatol Venereol 17(1):91-93, 2003
111. Schorr WF et al: Eosinophilic cellulitis (Wells' syndrome): histologic and clinical features in arthropod bite reactions. J Am Acad Dermatol 11(6):1043-1049, 1984
112. Aberer W, Konrad K, Wolff K: Wells' syndrome is a distinctive disease entity and not a histologic diagnosis. J Am Acad Dermatol 18(1 Pt 1):105-114, 1988
113. Peters MS, Schroeter AL, Gleich GJ: Immunofluorescence identification of eosinophil granule major basic protein in the flame figures of Wells' syndrome. Br J Dermatol 109(2):141-148, 1983
114. Brehmer-Andersson E et al: The histopathogenesis of the flame figure in Wells' syndrome based on five cases. Acta Derm Venereol 66(3):213-219, 1986
115. Caputo R et al: Wells syndrome in adults and children: A report of 19 cases. Arch Dermatol 142(9):1157-1161, 2006
116. Davis MD et al: Familial eosinophilic cellulitis, dysmorphic habitus, and mental retardation. J Am Acad Dermatol 38(6 Pt 1):919-928, 1998
117. Melski JW: Wells' syndrome, insect bites, and eosinophils. Dermatol Clin 8(2):287-293, 1990
118. Lin HL et al: Eosinophilic cellulitis after honeybee sting. J Formos Med Assoc 108(12):964-966, 2009
119. Gambichler T et al: Impetiginized Wells' syndrome in a patient with chronic lymphocytic leukaemia. Clin Exp Dermatol 34(7):e274-e275, 2009
120. Utikal J et al: Bullous eosinophilic cellulitis associated with ulcerative colitis: Effective treatment with
sulfasalazine and glucocorticoids.
Br J Dermatol 156(4):764-766, 2007
121. Hirsch K et al: Eosinophilic cellulitis (Wells' syndrome) associated with colon carcinoma. J Dtsch Dermatol Ges 3(7):530-531, 2005
122. Farrar CW, Guerin DM, Wilson NJ: Eosinophilic cellulitis associated with squamous cell carcinoma of the bronchus. Br J Dermatol 145(4):678-679, 2001
123. Hunt SJ, Santa Cruz DJ: Eosinophilic cellulitis: Histologic features in a cutaneous mastocytoma. Dermatologica 182(2):132-134, 1991
124. Koh KJ et al: Wells' syndrome following thiomersal-containing vaccinations. Australas J Dermatol 44(3):199-202, 2003
125. Calvert J et al: Relapse of Wells' syndrome in a child after tetanus-diphtheria immunization. J Am Acad Dermatol 54(Suppl. 5):S232-S233, 2006
126. Moreno M et al: Wells' syndrome related to tetanus vaccine. Int J Dermatol 36(7):524-525, 1997
127. Fujimoto N et al: Wells syndrome associated with Churg-Strauss syndrome. Clin Exp Dermatol 36(1):46-48, 2011
128. French LE et al: Eosinophilic fasciitis and eosinophilic cellulitis in a patient with abnormal circulating clonal T cells: Increased production of interleukin 5 and inhibition by interferon alfa. J Am Acad Dermatol 49(6):1170-1174, 2003
129. Nguyen NQ, Ma L: Eosinophilic cellulitis and dermographism. Dermatol Online J 11(4):7, 2005
130. Hamamoto Y et al: Eosinophilic cellulitis associated with molluscum contagiosum. Br J Dermatol 151(6):1279-1281, 2004
131. Ludwig RJ et al: Herpes simplex virus type 2-associated eosinophilic cellulitis (Wells' syndrome). J Am Acad Dermatol 48(Suppl. 5):S60-S61, 2003
132. Jones-Caballero M et al: Wells' syndrome and human immunodeficiency virus infection. Br J Dermatol 143(3):672-674, 2000
133. Beer TW et al: Flame figures in bullous pemphigoid. Dermatology 188(4):310-312, 1994
134. Rossini MS et al: Cutaneous adverse reaction to 2-chlorodeoxyadenosine with histological flame figures in patients with chronic lymphocytic leukaemia. J Eur Acad Dermatol Venereol 18(5):538-542, 2004
135. Winfield H et al: Eosinophilic cellulitislike reaction to subcutaneous
etanercept injection.
Arch Dermatol 142(2):218-220, 2006
136. Perrin C et al: Interstitial granulomatous drug reaction with a histological pattern of interstitial granulomatous dermatitis. Am J Dermatopathol 23(4):295-298, 2001
137. Moossavi M, Mehregan DR: Wells' syndrome: A clinical and histopathologic review of seven cases. Int J Dermatol 42(1):62-67, 2003
138. Espana A et al: Wells' syndrome (eosinophilic cellulitis): Correlation between clinical activity, eosinophil levels, eosinophil cation protein and interleukin-5. Br J Dermatol 140(1):127-130, 1999
139. Katoulis
AC et al: Idiopathic bullous eosinophilic cellulitis (Wells' syndrome).
Clin Exp Dermatol 34(7):e375-e376, 2009
140. Wells GC, Whimster IW: Subcutaneous angiolymphoid hyperplasia with eosinophilia. Br J Dermatol 81(1):1-14, 1969
141. Wilson-Jones E, Marks R: Papular angioplasia. Vascular papules of the face and scalp simulating malignant vascular tumors. Arch Dermatol 102(4):422-427, 1970
142. Jones EW, Bleehen SS: Inflammatory angiomatous nodules with abnormal blood vessels occurring about the ears and scalp (pseudo or atypical pyogenic granuloma). Br J Dermatol 81(11):804-816, 1969
143. Rosai J: Angiolymphoid hyperplasia with eosinophilia of the skin. Its nosological position in the spectrum of histiocytoid hemangioma. Am J Dermatopathol 4(2):175-84, 1982
144. Requena L, Sangueza OP: Cutaneous vascular proliferation. Part II. Hyperplasias and benign neoplasms. J Am Acad Dermatol 37(6):887-919, quiz 920-922, 1997
145. Zarrin-Khameh N, Spoden JE, Tran RM: Angiolymphoid hyperplasia with eosinophilia associated with pregnancy: A case report and review of the literature. Arch Pathol Lab Med 129(9):1168-1171, 2005
146. Gonzalez-Cuyar LF et al: Angiolymphoid hyperplasia with eosinophilia developing in a patient with history of peripheral T-cell lymphoma: evidence for multicentric T-cell lymphoproliferative process.
Diagn Pathol 3:22,.2008
[PubMed: 2427016]
147. Chen JF et al: Angiolymphoid hyperplasia with eosinophilia affecting the scrotum: A rare case report with molecular evidence of T-cell clonality. J Dermatol 37(4):355-359, 2010
148. Effat KG: Angiolymphoid hyperplasia with eosinophilia of the auricle: Progression of histopathological changes. J Laryngol Otol 120(5):411-413, 2006
149. Suzuki H et al: A case of angiolymphoid hyperplasia with eosinophilia (ALHE) of the upper lip. J Dermatol 32(12):991-995, 2005
150. Helander SD et al: Kimura's disease and angiolymphoid hyperplasia with eosinophilia: New observations from immunohistochemical studies of lymphocyte markers, endothelial antigens, and granulocyte proteins. J Cutan Pathol 22(4):319-326, 1995
151. Olsen TG, Helwig EB: Angiolymphoid hyperplasia with eosinophilia. A clinicopathologic study of 116 patients. J Am Acad Dermatol 12(5 Pt 1):781-796, 1985
152. Cheney ML et al: Angiolymphoid hyperplasia with eosinophilia (histiocytoid hemangioma): Evaluation of treatment options. Ann Otol Rhinol Laryngol 102(4 Pt 1):303-308, 1993
153. Miller CJ, Ioffreda MD, Ammirati CT: Mohs micrographic surgery for angiolymphoid hyperplasia with eosinophilia. Dermatol Surg 30(8):1169-1173, 2004
154. Rampini P et al: Angiolymphoid hyperplasia with eosinophilia: Successful treatment with interferon alpha 2b. Dermatology 202(4):343, 2001
155. Cooper SM, Dawber RP, Millard P: Angiolymphoid hyperplasia with eosinophilia treated by cryosurgery. J Eur Acad Dermatol Venereol 15(5):489-490, 2001
156. Angel CA et al: Angiolymphoid hyperplasia successfully treated with an ultralong pulsed dye laser. Dermatol Surg 31(6):713-716, 2005
157. Mashiko M et al: A case of angiolymphoid hyperplasia with eosinophilia successfully treated with
tacrolimus ointment.
Br J Dermatol 154(4):803-804, 2006
158. Chen H et al: Kimura disease: A clinicopathologic study of 21 cases. Am J Surg Pathol 28(4):505-513, 2004
159. Kimura T, Yoshimura S, Ishikawa E: Unusual granulation combined with hyperplastic changes in lymphatic tissue. Trans Soc Pathol Jpn 13:179-180, 1948
160. Kung IT, Gibson JB, Bannatyne PM: Kimura's disease: A clinico-pathological study of 21 cases and its distinction from angiolymphoid hyperplasia with eosinophilia. Pathology 16(1):39-44, 1984
161. Li TJ et al: Kimura's disease: A clinicopathologic study of 54 Chinese patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 82(5):549-555, 1996
162. Wang TF et al: Kimura's disease with generalized lymphadenopathy demonstrated by positron emission tomography scan. Intern Med 45(12):775-778, 2006
163. Yamada A et al: Membranous glomerulonephritis associated with eosinophilic lymphfolliculosis of the skin (Kimura's disease): Report of a case and review of the literature. Clin Nephrol 18(4):211-215, 1982
164. Rajpoot DK, Pahl M, Clark J: Nephrotic syndrome associated with Kimura disease. Pediatr Nephrol 14(6):486-488, 2000
165. Wang DY et al: Kimura disease: A case report and review of the Chinese literature. Nephron Clin Pract 111(1):c55-c61, 2009
166. Chong WS, Thomas A, Goh CL: Kimura's disease and angiolymphoid hyperplasia with eosinophilia: Two disease entities in the same patient: Case report and review of the literature. Int J Dermatol 45(2):139-145, 2006
167. Yuen HW et al: Kimura's disease: A diagnostic and therapeutic challenge. Singapore Med J 46(4):179-183, 2005
168. Takeishi M et al: Kimura disease: Diagnostic imaging findings and surgical treatment. J Craniofac Surg 18(5):1062-1067, 2007
169. Wang YS et al: Treatment of Kimura's disease with
cyclosporine.
J Dermatolog Treat 16(4):242-244, 2005
170. Abuel-Haija M, Hurford MT: Kimura disease. Arch Pathol Lab Med 131(4):650-651, 2007
171. Sun QF et al: Kimura disease: Review of the literature. Intern Med J 38(8):668-672, 2008
172. Ofuji S et al: Eosinophilic pustular folliculitis. Acta Derm Venereol 50(3):195-203, 1970
173. Lucky AW et al: Eosinophilic pustular folliculitis in infancy. Pediatr Dermatol 1(3):202-206, 1984
174. Soeprono FF, Schinella RA: Eosinophilic pustular folliculitis in patients with acquired immunodeficiency syndrome. Report of three cases. J Am Acad Dermatol 14(6):1020-1022, 1986
175. Ziemer M, Boer A: Eosinophilic pustular folliculitis in infancy: Not a distinctive inflammatory disease of the skin. Am J Dermatopathol 27(5):443-455, 2005
176. Nervi SJ, Schwartz RA, Dmochowski M: Eosinophilic pustular folliculitis: A 40 year retrospect. J Am Acad Dermatol 55(2):285-289, 2006
177. Takematsu H et al: Eosinophilic pustular folliculitis. Report of two cases with a review of the Japanese literature. Arch Dermatol 121(7):917-920, 1985
178. Rosenthal D et al: Human immunodeficiency virus-associated eosinophilic folliculitis. A unique dermatosis associated with advanced human immunodeficiency virus infection. Arch Dermatol 127(2):206-209, 1991
179. Rajendran PM et al: Eosinophilic folliculitis: Before and after the introduction of antiretroviral therapy. Arch Dermatol 141(10):1227-1231, 2005
180. Kimoto M, Ishihara S, Konohana A: Eosinophilic pustular folliculitis with polycythemia vera. Dermatology 210(3):239-240, 2005
181. Patrizi A et al: Eosinophilic pustular folliculitis (Ofuji's disease) and non-Hodgkin lymphoma. Acta Derm Venereol 72(2):146-147, 1992
182. Jang KA et al: Eosinophilic pustular folliculitis (Ofuji's disease) in myelodysplastic syndrome. J Dermatol 25(11):742-746, 1998
183. Lambert J et al: Eosinophilic pustular folliculitis and B-cell chronic lymphatic leukaemia. Dermatology 189(Suppl. 2):58-59, 1994
184. Keida T, Hayashi N, Kawashima M: Eosinophilic pustular folliculitis following autologous peripheral blood stem-cell transplantation. J Dermatol 31(1):21-26, 2004
185. Goiriz R et al: Eosinophilic folliculitis following allogeneic peripheral blood stem cell transplantation: Case report and review. J Cutan Pathol 34(Suppl. 1):33-36, 2007
186. Fraser SJ et al: Eosinophilic folliculitis: An important differential diagnosis after allogeneic bone-marrow transplant. Clin Exp Dermatol 34(3):369-371, 2009
187. Ogawa E et al: Eosinophilic pustular folliculitis occurring after bone marrow transplantation in a child with aplastic anaemia. Acta Derm Venereol 89(2):200-201, 2009
188. Opie KM et al: Two cases of eosinophilic pustular folliculitis associated with parasitic infestations. Australas J Dermatol 44(3):217-219, 2003
189. Gesierich A et al: Eosinophilic folliculitis in a Caucasian patient: Association with toxocariasis? J Eur Acad Dermatol Venereol 20(10):1317-1321, 2006
190. Kuo TT, Chen SY, Chan HL: Tinea infection histologically simulating eosinophilic pustular folliculitis. J Cutan Pathol 13(2):118-122, 1986
191. Haupt HM, Stern JB, Weber CB: Eosinophilic pustular folliculitis: Fungal folliculitis? J Am Acad Dermatol 23(5 Pt 2):1012-1014, 1990
192. Shindo M et al: Trichophyton rubrum infection histologically identical to eosinophilic pustular folliculitis. Clin Exp Dermatol 33(4):500-501, 2008
193. Maejima H, Mukai H, Hikaru E: Eosinophilic pustular folliculitis induced by
allopurinol and timepidium bromide.
Acta Derm Venereol 82(4):316-317, 2002
194. Mizoguchi S et al: Eosinophilic pustular folliculitis induced by
carbamazepine.
J Am Acad Dermatol 38(4):641-643, 1998
195. Kishimoto S et al: Eosinophilic pustular folliculitis in association with nevoid basal cell carcinoma syndrome. Acta Derm Venereol 81(3):202-204, 2001
196. Kus S et al: Eosinophilic pustular folliculitis (Ofuji's disease) exacerbated with pregnancies. J Eur Acad Dermatol Venereol 20(10):1347-1348, 2006
197. Kimura K et al: A case of eosinophilic pustular folliculitis (Ofuji's disease) induced by patch and challenge tests with indeloxazine hydrochloride. J Dermatol 23(7):479-483, 1996
198. Takematsu H, Tagami H: Eosinophilic pustular folliculitis. Studies on possible chemotactic factors involved in the formation of pustules. Br J Dermatol 114(2):209-215, 1986
199. Selvaag E et al: Eosinophil cationic protein in eosinophilic pustular folliculitis: An immunohistochemical investigation. Clin Exp Dermatol 22(5):255-256, 1997
200. Fushimi M et al: Eosinophilic pustular folliculitis effectively treated with recombinant interferon-gamma: Suppression of mRNA expression of interleukin 5 in peripheral blood mononuclear cells. Br J Dermatol 134(4):766-772, 1996
201. Otsuka A et al: Treatment of eosinophilic pustular folliculitis with ciclosporin: Suppression of mRNA expression of IL-4 and IL-13. J Eur Acad Dermatol Venereol 24(12):1489-1491, 2010
202. Asgari M et al: Neonatal eosinophilic pustulosis. Int J Dermatol 45(2):131-134, 2006
203. McCalmont TH et al: Eosinophilic folliculitis. The histologic spectrum. Am J Dermatopathol 17(5):439-446, 1995
204. Buezo GF et al: HIV-Associated eosinophilic folliculitis and follicular mucinosis. Dermatology 197(2):178-180, 1998
205. Lee MW et al: Failure to detect clonality in eosinophilic pustular folliculitis with follicular mucinosis. Acta Derm Venereol 84(4):305-307, 2004
206. Kabashima K, Sakurai T, Miyachi Y: Treatment of eosinophilic pustular folliculitis (Ofuji's disease) with
tacrolimus ointment.
Br J Dermatol 151(4):949-950, 2004
207. Ellis E, Scheinfeld N: Eosinophilic pustular folliculitis: A comprehensive review of treatment options. Am J Clin Dermatol 5(3):189-197, 2004
208. Fukamachi S et al: Therapeutic effectiveness of various treatments for eosinophilic pustular folliculitis. Acta Derm Venereol 89(2):155-159, 2009
209. Ota T et al: Eosinophilic pustular folliculitis (Ofuji's disease):
Indomethacin as a first choice of treatment.
Clin Exp Dermatol 26(2):179-181, 2001
210. Satoh T et al: Indomethacin-induced reduction in CRTH2 in eosinophilic pustular folliculitis (Ofuji's disease): A proposed mechanism of action. Acta Derm Venereol 90(1):18-22, 2010
211. Burgess GH, Mehregan AH, Drinnan AJ: Eosinophilic ulcer of the tongue. Arch Dermatol 113(5):644-645, 1977
212. Mezei MM et al: Eosinophilic ulcer of the oral mucosa. J Am Acad Dermatol 33(5 Pt 1):734-740, 1995
213. el-Mofty SK et al: Eosinophilic ulcer of the oral mucosa. Report of 38 new cases with immunohistochemical observations. Oral Surg Oral Med Oral Pathol 75(6):716-722, 1993
214. Segura S, Pujol RM: Eosinophilic ulcer of the oral mucosa: A distinct entity or a non-specific reactive pattern? Oral Dis 14(4):287-295, 2008
215. Segura S et al: Eosinophilic ulcer of the oral mucosa: Another histological simulator of CD30 +lymphoproliferative disorders. Br J Dermatol 155(2):460-463, 2006
216. Cheng JF et al: Dermal eosinophils in atopic dermatitis undergo cytolytic degeneration. J Allergy Clin Immunol 99(5):683-692, 1997
217. Davis MD et al: Interactions of eosinophil granule proteins with skin: Limits of detection, persistence, and vasopermeabilization. J Allergy Clin Immunol 112(5):988-994, 2003
218. Peters MS et al: Localization of eosinophil granule major basic protein in chronic urticaria. J Invest Dermatol 81(1):39-43, 1983
219. Peters MS et al: Extracellular deposition of eosinophil granule major basic protein in pressure urticaria. J Am Acad Dermatol 16(3 Pt 1):513-517, 1987
220. Leiferman KM et al: Evidence for eosinophil degranulation with deposition of granule major basic protein in solar urticaria. J Am Acad Dermatol 21(1):75-80, 1989
221. McEvoy MT et al: Immunohistological comparison of granulated cell proteins in induced immediate urticarial dermographism and delayed pressure urticaria lesions. Br J Dermatol 133(6):853-860, 1995
222. Katzen DR et al: Hypereosinophilia and recurrent angioneurotic edema in a 2 1/2-year-old girl. Am J Dis Child 140(1):62-64, 1986
223. Songsiridej V et al: Facial edema and eosinophilia. Evidence for eosinophil degranulation. Ann Intern Med 103(4):503-506, 1985
224. Wolf C et al: Episodic angioedema with eosinophilia. J Am Acad Dermatol 20(1):21-27, 1989
225. Putterman C et al: Episodic angioedema with eosinophilia: A case associated with T cell activation and cytokine production. Ann Allergy 70(3):243-248, 1993
226. Butterfield JH et al: Elevated serum levels of interleukin-5 in patients with the syndrome of episodic angioedema and eosinophilia. Blood 79(3):688-692, 1992
227. Morgan SJ et al: Clonal T-helper lymphocytes and elevated IL-5 levels in episodic angioedema and eosinophilia (Gleich's syndrome). Leuk Lymphoma 44(9):1623-1625, 2003
228. van Haelst Pisani C et al: Administration of interleukin-2 (IL-2) results in increased plasma concentrations of IL-5 and eosinophilia in patients with cancer. Blood 78(6):1538-1544, 1991
229. Mehregan DR et al: Cutaneous reactions to granulocyte-monocyte colony-stimulating factor. Arch Dermatol 128(8):1055-1059, 1992
230. Kephart GM et al: Deposition of eosinophil granule major basic protein onto microfilariae of Onchocerca volvulus in the skin of patients treated with
diethylcarbamazine.
Lab Invest 50(1):51-61, 1984
231. Leiferman KM et al: Dermal deposition of eosinophil-granule major basic protein in atopic dermatitis. Comparison with onchocerciasis. N Engl J Med 313(5):282-285, 1985
232. Ackerman SJ et al: Eosinophil degranulation. An immunologic determinant in the pathogenesis of the Mazzotti reaction in human onchocerciasis. J Immunol 144(10):3961-3969, 1990
233. Leiferman KM et al:. Eosinophils. In: Atopic Dermatitis, 2nd edition, edited by T Bieber, DYM Leung. New York, Informa Healthcare USA, 2009, Chapter 10, pp. 195-228
234. Cheung PF et al: Activation of human eosinophils and epidermal keratinocytes by Th2 cytokine IL-31: Implication for the immunopathogenesis of atopic dermatitis. Int Immunol 22(6):453-467, 2010
235. Perez GL et al: Mast cells, neutrophils, and eosinophils in prurigo nodularis. Arch Dermatol 129(7):861-865, 1993
236. Jacyk WK et al: Pachydermatous eosinophilic dermatitis. Br J Dermatol 134(3):469-474, 1996
237. Johansson O et al: Eosinophil cationic protein- and eosinophil-derived neurotoxin/eosinophil protein X-immunoreactive eosinophils in prurigo nodularis. Arch Dermatol Res 292(8):371-378, 2000
238. Suto H et al: NC/Nga mice: A mouse model for atopic dermatitis. Int Arch Allergy Immunol 120(Suppl. 1):70-75, 1999
239. Tsukuba T et al: Association of cathepsin E deficiency with development of atopic dermatitis. J Biochem (Tokyo) 134(6):893-902, 2003
240. Yagi R et al: Development of atopic dermatitis-like skin lesions in STAT6-deficient NC/Nga mice. J Immunol 168(4):2020-2027, 2002
241. Chan LS, Robinson N, Xu L: Expression of interleukin-4 in the epidermis of transgenic mice results in a pruritic inflammatory skin disease: An experimental animal model to study atopic dermatitis. J Invest Dermatol 117(4):977-983, 2001
242. Fang D et al: Dysregulation of T lymphocyte function in itchy mice: A role for Itch in TH2 differentiation. Nat Immunol 3(3):281-287, 2002
243. Bahrami S et al: Tissue eosinophilia as an indicator of drug-induced cutaneous small-vessel vasculitis. Arch Dermatol 142(2):155-161, 2006
244. Bocquet H, Bagot M, Roujeau JC: Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS). Semin Cutan Med Surg 15(4):250-257, 1996
245. Lens S et al: Severe acute hepatitis in the dress syndrome: Report of two cases. Ann Hepatol 9(2):198-201, 2010
246. Ramdial PK, Naidoo DK. Drug-induced cutaneous pathology. J Clin Pathol 62(6):493-504, 2009
247. Borrego L et al: Deposition of eosinophil granule proteins precedes blister formation in bullous pemphigoid. Comparison with neutrophil and mast cell granule proteins. Am J Pathol 148(3):897-909, 1996
248. Stahle-Backdahl M et al: 92-kD gelatinase is produced by eosinophils at the site of blister formation in bullous pemphigoid and cleaves the extracellular domain of recombinant 180-kD bullous pemphigoid autoantigen. J Clin Invest 93(5):2022-2030, 1994
249. Shrikhande M, Hunziker T, Braathen LR, Pichler WJ, Dahinden CA, Yawalkar N: Increased co-expression of eotaxin and interleukin 5 in bullous pemphigoid. Acta Derm Venereol 80:277-280, 2000
250. Scheman AJ et al: Evidence for eosinophil degranulation in the pathogenesis of herpes gestationis. Arch Dermatol 125(8):1079-1083, 1989
251. Borrego L et al: Polymorphic eruption of pregnancy and herpes gestationis: Comparison of granulated cell proteins in tissue and serum. Clin Exp Dermatol 24(3):213-225, 1999
252. Ambros-Rudolph CM et al: The specific dermatoses of pregnancy revisited and reclassified: Results of a retrospective two-center study on 505 pregnant patients. J Am Acad Dermatol 54(3):395-404, 2006
253. Roger D et al: Specific pruritic diseases of pregnancy. A prospective study of 3192 pregnant women. Arch Dermatol 130(6):734-739, 1994
254. Noguchi H et al: Tissue eosinophilia and eosinophil degranulation in syndromes associated with fibrosis. Am J Pathol 140(2):521-528, 1992
255. Pegorier S et al: Eosinophil-derived cationic proteins activate the synthesis of remodeling factors by airway epithelial cells. J Immunol 177(7):4861-4869, 2006
256. Antic M, Lautenschlager S, Itin PH: Eosinophilic fasciitis 30 years after – What do we really know? Report of 11 patients and review of the literature. Dermatology 213(2):93-101, 2006
257. Hertzman PA et al: Association of the eosinophilia-myalgia syndrome with the ingestion of
tryptophan.
N Engl J Med 322(13):869-873, 1990
258. Mori Y, Kahari VM, Varga J: Scleroderma-like cutaneous syndromes. Curr Rheumatol Rep 4(2):113-122, 2002
259. Varga J et al: Eosinophilic fasciitis is clinically distinguishable from the eosinophilia-myalgia syndrome and is not associated with L-tryptophan use. J Rheumatol 18(2):259-263, 1991
260. Varga J, Kahari VM: Eosinophilia-myalgia syndrome, eosinophilic fasciitis, and related fibrosing disorders. Curr Opin Rheumatol 9(6):562-570, 1997
261. Uitto J et al: Eosinophilia-myalgia syndrome. Int J Dermatol 31(4):223-228, 1992
262. Martin RW et al: The clinical spectrum of the eosinophilia-myalgia syndrome associated with L-tryptophan ingestion. Clinical features in 20 patients and aspects of pathophysiology. Ann Intern Med 113(2):124-134, 1990
263. Diggle GE: The toxic oil syndrome: 20 years on. Int J Clin Pract 55(6):371-375, 2001
264. Ten RM et al: Participation of eosinophils in the toxic oil syndrome. Clin Exp Immunol 82(2):313-317, 1990
265. Martinez-Cabot A, Messeguer A: Generation of quinoneimine intermediates in the bioactivation of 3-(N-phenylamino)alanine (PAA) by human liver microsomes: A potential link between eosinophilia-myalgia syndrome and toxic oil syndrome. Chem Res Toxicol 20(10):1556-1562, 2007
266. Rieber N, Belohradsky BH: AHR activation by tryptophan–Pathogenic hallmark of Th17-mediated inflammation in eosinophilic fasciitis, eosinophilia-myalgia-syndrome and toxic oil syndrome? Immunol Lett 128(2):154-155, 2010
267. Churg J, Strauss L: Allergic granulomatosis, allergic angiitis, and periarteritis nodosa. Am J Pathol 27(2):277-301, 1951
268. Davis MD et al: Cutaneous manifestations of Churg-Strauss syndrome: A clinicopathologic correlation. J Am Acad Dermatol 37(2 Pt 1):199-203, 1997
269. Drage LA et al: Evidence for pathogenic involvementof eosinophils and neutrophilsin Churg-Strauss syndrome. J Am Acad Dermatol 47(2):209-216, 2002
270. Ishibashi M et al: Churg-Strauss syndrome with coexistence of eosinophilic vasculitis, granulomatous phlebitis and granulomatous dermatitis in bullous pemphigoid-like blisters. J Cutan Pathol 38(3):290-294, 2011
271. Chen KR et al: Recurrent cutaneous necrotizing eosinophilic vasculitis. A novel eosinophil-mediated syndrome. Arch Dermatol 130(9):1159-1166, 1994
272. Carlson JA, Chen KR: Cutaneous vasculitis update: Neutrophilic muscular vessel and eosinophilic, granulomatous, and lymphocytic vasculitis syndromes. Am J Dermatopathol 29(1):32-43, 2007
273. Chen KR et al: Eosinophilic vasculitis in connective tissue disease. J Am Acad Dermatol 35(2 Pt 1):173-182, 1996
274. Cormier SA et al: Pivotal Advance: Eosinophil infiltration of solid tumors is an early and persistent inflammatory host response. J Leukoc Biol 79(6):1131-1139, 2006
275. van Doorn R, Scheffer E, Willemze R: Follicular mycosis fungoides, a distinct disease entity with or without associated follicular mucinosis: A clinicopathologic and follow-up study of 51 patients. Arch Dermatol 138(2):191-198, 2002
276. Shapiro PE, Pinto FJ: The histologic spectrum of mycosis fungoides/Sezary syndrome (cutaneous T-cell lymphoma). A review of 222 biopsies, including newly described patterns and the earliest pathologic changes. Am J Surg Pathol 18(7):645-667, 1994
277. Kong YY et al: Neutrophil/eosinophil-rich type of primary cutaneous anaplastic large cell lymphoma: A clinicopathological, immunophenotypic and molecular study of nine cases. Histopathology 55(2):189-196, 2009
278. Davis MD et al: Exaggerated arthropod-bite lesions in patients with chronic lymphocytic leukemia: A clinical, histopathologic, and immunopathologic study of eight patients. J Am Acad Dermatol 39(1):27-35, 1998
279. Rueda RA et al: Eosinophilic, polymorphic, and pruritic eruption associated with radiotherapy. Arch Dermatol 135:804-810, 1999
280. Delaibatiki M, Hardie C, Temple-Camp C: Eosinophilic, polymorphic, and pruritic eruption associated with radiotherapy after chest wall irradiation. NZMJ 122:99-101, 2009